Transcept Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financi...(eemed dividend - Series C convertibl...),Health

Date:3/23/2009

eemed dividend - Series C convertible preferred stockholders - - (457,874) --- --- -------- Loss attributable to common stockholders $(19,959,375) $(20,384,506) $(65,569,307) ============ ============ ============ Basic and diluted net loss per share $(7.03) $(9.74) ====== ====== Weighted average common shares outstanding 2,837,698 2,093,686 ========= ========= Transcept Pharmaceuticals, Inc. Balance Sheets December 31, ------------ 2008 2007 ---- ---- Assets Current assets: Cash and cash equivalents $4,431,505 $5,695,849 Marketable securities 7,250,987 29,537,876 Prepaid and other current assets 381,836 531,892 Restricted cash 200,000 200,000 ------- ------- Total current assets 12,264,328 35,965,617 Property and equipment, net 1,450,216 1,700,253 Other assets 65,970 102,851 ------ ------- Total assets $13,780,514 $37,768,721 =========== =========== Liabilities, conv
'/>"/>

SOURCE Transcept Pharmaceuticals, Inc. Copyright©2009 PR Newswire. All rights reserved

1 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12
Related medicine news :

1. Transcept Pharmaceuticals to Report Fourth Quarter 2008 Results
2. Transcept Pharmaceuticals to Present at Two Upcoming Conferences
3. Transcept Pharmaceuticals, Inc. Completes Merger with Novacea, Inc.
4. Transcept Pharmaceuticals to Participate on Drug Delivery Investor Panel
5. Transcept Pharmaceuticals, Inc. to Present at the 20th Annual Piper Jaffray Health Care Conference
6. Transcept Pharmaceuticals to Present at the Jefferies 2nd Annual Healthcare Conference
7. Transcept Pharmaceuticals to Present at the BioCentury Future Leaders in the Biotech Industry Conference
8. Transcept Pharmaceuticals to Present at Cowen and Companys 27th Annual Health Care Conference in Boston
9. Transcept Pharmaceuticals to Present at the Susquehanna Financial Groups SIGnificant Investment Options in Healthcare Conference
10. Transcept Pharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference
11. Transcept Pharmaceuticals to Present at the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference